ClassID:

97035

C07K14/70525 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants; Immunoglobulin superfamily ICAM molecules, e.g. CD50, CD54, CD102

Recent Application in this class:
#1
20250288662
2025-09-18

MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS

#2
20250049845
2025-02-13

METHODS AND COMPOSITIONS FOR NATURAL KILLER CELLS

#3
20240156950
2024-05-16

EXTRACELLULAR VESICLE-BASED NANOCARRIERS

#4
20240009308
2024-01-11

CHIMERIC ANTIGEN RECEPTOR COMPRISING NOVEL CO-STIMULATORY DOMAIN AND USE THEREOF

#5
20230338528
2023-10-26

SYSTEMS AND METHODS FOR ENHANCED IMMUNOTHERAPIES

#6
20220389094
2022-12-08

Compositions and Methods for Treating Cancer with Anti-ROR1 Immunotherapy

#7
20220331362
2022-10-20

METHODS OF B CELL EXPANSION FOR USE IN CELL THERAPY

#8
20220233603
2022-07-28

DENDRITIC CELL-BASED CANCER VACCINES AND PREPARATION METHOD THEREOF

#9
20220143092
2022-05-12

Methods and compositions for natural killer cells

#10
20210338788
2021-11-04

Compositions and methods for enhancing the stability of transgenes in poxviruses

#11
20210198689
2021-07-01

Multimodal Vector for Dendritic Cell Infection

#12
20210145796
2021-05-20

METHODS FOR ADMINISTERING COMPOSITIONS INCLUDING INTEGRIN AGONISTS HAVING ANTI-TUMOR ACTIVITY

#13
20210069244
2021-03-11

Pharmaceutical chimeric receptor composition and method thereof

#14
20200102385
2020-04-02

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

#15
20200061174
2020-02-27

Compositions and methods for enhancing the stability of transgenes in poxviruses

#16
20190352616
2019-11-21

MULTIPLE TRANSGENE RECOMBINANT ADENOVIRUS

#17
20190247317
2019-08-15

ICAM-1 TARGETING ELPS

#18
20190125891
2019-05-02

COMPOSITIONS AND METHODS FOR TISSUE REPAIR

#19
20190055309
2019-02-21

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

#20
20170333479
2017-11-23

Methods and compositions for natural killer cells

#21
20160000755
2016-01-07

Compositions and methods to improve adoptive cell therapies

#22
20130004490
2013-01-03

DELIVERY OF TRANSTHYRETIN ACROSS THE BLOOD-BRAIN BARRIER AS A TREATMENT FOR ALZHEIMER'S DISEASE

#23
20120100160
2012-04-26

Methods for Inducing Mixed Chimerism

#24
20100317054
2010-12-16

Porcine DC-SIGN, ICAM-3 and LSECtin and uses thereof

#25
20100291080
2010-11-18

Compositions and methods for tissue repair

#26
20090156519
2009-06-18

Modified KSA and Uses Thereof

#27
20090041804
2009-02-12

Recombinant vector expressing multiple costimulatory molecules and uses thereof

#28
20090035321
2009-02-05

Intercellular adhesion molecules and their binding ligands

#29
20080219999
2008-09-11

Immunoadhesin comprising a chimeric ICAM-1 molecule produced in a plant

#30
20070060522
2007-03-15

Soluble fibrin inhibitory peptides and uses thereof

#31
20070009952
2007-01-11

Nephrin gene and protein

#32
20060252116
2006-11-09

Icam-4 binding sites

#33
20060198855
2006-09-07

Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection

#34
20060123496
2006-06-08

Animal models

#35
20050176020
2005-08-11

I-CAM related protein

#36
20050026152
2005-02-03

Methods of screening for schizophrenia